EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Aesthetic Medical International Holdings Group Limited (PAIYY) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Aesthetic Medical International Holdings Group Limited $0.02, price $0.02, upside -2.9%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · ISIN US00809M1045

AM Aesthetic Medical International Holdings Group Limited logo Thin data Sep 23, 2026

Aesthetic Medical International Holdings Group Limited

PAIYY · US

Low PriorityFair Value upside is limited and quality is weak.

·Fair value $0.0165 · Fairly valued (−3%)
!Quality 33/100
!Weak Growth (revenue 5y −4.8 %/yr)
!Loss-making · -7.4% net margin (TTM)
!Negative equity (buybacks among others) · negative free cash flow
!Trails peers (0/6)
!Narrow moat 7/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 29 out of 100
Watch Aesthetic Medical International Holdings Group Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$9.08 $0.0140 Fair Value $0.0165 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $0.0140 – $9.08 · fair‑value band $0.0164 – $0.0166 · the $0.0170 price screens above the $0.0165 fair value. Dashed = 300-day average. As of Sep 23, 2026.

Follow Aesthetic Medical International Holdings Group in your weekly email

Every Wednesday you see whether Aesthetic Medical International Holdings Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China.

Show more

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye lid surgery, rhinoplasty, breast augmentation, liposuction, facelifts; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.

Stock analysis

Aesthetic Medical International Holdings Group Limited (PAIYY) currently trades at $0.0170, while our model-based Fair Value estimate is $0.0165, implying the stock looks roughly 3.0% fairly valued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $0.0294 per share, and 3 of the 5 models we run sit above the $0.0170 price.

Bear case: the Earnings-Based group reads lowest at $0.0165, and 2 of the 5 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.0164 (bear) to $0.0166 (bull), the price of $0.0170 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Aesthetic Medical International Holdings Group Limited reported revenue of 703M CNY in FY2025 versus 646M CNY in FY2021, a compound +2.2%/yr. Reported net income was −51.9M CNY in FY2025.

Key figures

Market cap $730K · EPS (TTM) $−0.1800 · Net margin −7.4% · Return on equity −204% · Return on assets (EBIT) −14.3% · Operating margin 0.3% · Revenue (TTM) 723M CNY · Revenue growth (YoY) −5.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 95% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −3%, PAIYY screens richer than that median.

Fair Value models

Bear $0.0164 Fair Value $0.0165 Bull $0.0166
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV $0.0158 $0.0165 $0.0173 74
ROIC Compounder $0.0158 $0.0165 $0.0173 72
EV/EBITDA $0.1514 $0.1984 $0.2452 67
All 5 models by family
Earnings-Based
EPV $0.0158 $0.0165 $0.0173 74
Multiples
EV/EBIT $0.0248 $0.0294 $0.0340 66
EV/EBITDA $0.1514 $0.1984 $0.2452 67
EV/Revenue $0.0207 $0.0250 $0.0293 54
Economic Profit
ROIC Compounder $0.0158 $0.0165 $0.0173 72

Open the full fair value analysis →

Notify me when PAIYY reaches fair value

Put PAIYY on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 33/100

Of which business quality 33 · Market factors (momentum, volatility) 25

Profitability 50
Margins and returns on capital today
Quality Growth 21
Are margins and returns improving?
Cashflow 5
Earnings quality: real cash, not paper profit
Fin. Strength 12
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 22
Price trend over the last 3–12 months (market factor)
52W Momentum 1
Distance to the 52-week high (market factor)
Net Issuance 40
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−6.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.8%
Start year 2020 (pandemic)
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−21.8% (2020) → 0.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch PAIYY, get fair value alerts →

Compare Aesthetic Medical International Holdings Group Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks

Beats the industry median on 0/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 33 · Bottom 25%
Fair Value upside −3% · Below median
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets 1% · Bottom 25%
Net margin (TTM) −7% · Bottom 25%
Operating margin (TTM) 0% · Bottom 25%
Growth and dividend
Revenue growth −5% · Bottom 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)29 · sector 33
FUTURE (revenue growth)0 · sector 28
PAST (return on equity)0 · sector 31
HEALTH (low debt)0 · sector 89
DIVIDEND (yield)0 · sector 43

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $436.48 $592.64 +36%
Fresenius SE FRE €45.74 €34.54 −24%
Dr. Sulaiman Al Habib Medical Services Group 4013 227.50 SAR 109.45 SAR −52%
IHH Healthcare Berhad, an investment holding company, 5225 8.00 MYR 4.87 MYR −39%
Tenet Healthcare Corporation THC $256.44 $399.58 +56%
DaVita Inc DVA $183.14 $255.97 +40%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹9,069 ₹2,908 −68%
Fresenius Medical Care AG FME €39.35 €71.28 +81%
Aier Eye Hospital Group 300015 ¥8.07 ¥10.86 +35%
Encompass Health Corporation EHC $122.76 $96.51 −21%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Aesthetic Medical International Holdings Group Limited · Fair Value
$0.0165 −3%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Aesthetic Medical International Holdings Group Limited Fair Value". https://www.fairvalue-calculator.com/stock/PAIYY

Frequently asked questions

Is Aesthetic Medical International Holdings Group Limited (PAIYY) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.0165 versus a price of $0.0170, about −3% upside (fairly valued).
What is the fair value of PAIYY?
Our model-based fair value for Aesthetic Medical International Holdings Group Limited is $0.0165 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.0170.
What is the quality score of PAIYY?
Aesthetic Medical International Holdings Group Limited has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Aesthetic Medical International Holdings Group Limited (PAIYY)?
Our model-based price target is the fair value of $0.0165 (as of Sep 23, 2026) from 5 valuation models. Cautious scenario $0.0164, optimistic scenario $0.0166. It is a calculation from audited fundamentals, not an analyst target.
What is the Aesthetic Medical International Holdings Group Limited stock forecast for 2026?
Our models put fair value at $0.0165, about −3% upside versus a price of $0.0170 (fairly valued). Cautious scenario $0.0164, optimistic scenario $0.0166. The calculation is refreshed regularly with new filings.
What is the revenue of Aesthetic Medical International Holdings Group Limited (PAIYY)?
Aesthetic Medical International Holdings Group Limited reported trailing-twelve-month revenue of about 723M CNY (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Aesthetic Medical International Holdings Group Limited (PAIYY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Aesthetic Medical International Holdings Group Limited it is $0.0165 per share (as of Sep 23, 2026), against a price of $0.0170. It is the blended result of 5 valuation models (cash flow, earnings, asset, dividend).
Is Aesthetic Medical International Holdings Group Limited stock overvalued or undervalued in 2026?
As of Sep 23, 2026, PAIYY trades above its calculated fair value: price $0.0170, fair value $0.0165, a gap of about −3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PAIYY?
No. The price is what the market pays today ($0.0170); the fair value is what the company's own numbers justify ($0.0165). For Aesthetic Medical International Holdings Group Limited the two are $0.0005 per share apart. That gap is exactly why we show both numbers side by side.
How much is Aesthetic Medical International Holdings Group Limited worth?
The market values Aesthetic Medical International Holdings Group Limited at about $730K (market capitalisation, as of Sep 23, 2026). Per share that is $0.0170; our models calculate a fair value of $0.0165 per share.
What do the bullish and bearish scenarios say about PAIYY?
Our models span a range for Aesthetic Medical International Holdings Group Limited: cautious scenario $0.0164, base $0.0165, optimistic $0.0166 per share (as of Sep 23, 2026, price $0.0170). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Aesthetic Medical International Holdings Group Limited (PAIYY)?
Balance-sheet figures for Aesthetic Medical International Holdings Group Limited (as of Sep 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is PAIYY from its 52-week high?
Aesthetic Medical International Holdings Group Limited trades at $0.0170, about 95% below its 52-week high of $0.3200 and 21% above the low of $0.0140 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0165 is for.
Which stocks are comparable to Aesthetic Medical International Holdings Group Limited?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Aesthetic Medical International Holdings Group Limited stock attractive at the current price?
The data as of Sep 23, 2026: price $0.0170, calculated fair value $0.0165 (−3%), Quality Score 33/100, from 5 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PAIYY calculated?
We run Aesthetic Medical International Holdings Group Limited through 5 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0165, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Aesthetic Medical International Holdings Group Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Aesthetic Medical International Holdings Group Limited (PAIYY)?
The closing price on Sep 23, 2026 was $0.0170. Our model-based fair value is $0.0165, about −3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Aesthetic Medical International Holdings Group Limited right now?
The price sits above even our optimistic bull case ($0.0166). The favourable scenario is already priced in. The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0164 to $0.0166), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Aesthetic Medical International Holdings Group Limited

How large is the market capitalisation of Aesthetic Medical International Holdings Group Limited (PAIYY)?
The market capitalisation of Aesthetic Medical International Holdings Group Limited is $730K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Aesthetic Medical International Holdings Group Limited (PAIYY)?
Earnings per share at Aesthetic Medical International Holdings Group Limited are $−0.1800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Aesthetic Medical International Holdings Group Limited (PAIYY)?
The net margin of Aesthetic Medical International Holdings Group Limited is −7.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Aesthetic Medical International Holdings Group Limited (PAIYY)?
The return on equity (ROE) of Aesthetic Medical International Holdings Group Limited is −204% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Aesthetic Medical International Holdings Group Limited (PAIYY)?
On an EBIT basis the return on assets of Aesthetic Medical International Holdings Group Limited is −14.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Aesthetic Medical International Holdings Group Limited (PAIYY)?
The operating margin of Aesthetic Medical International Holdings Group Limited is 0.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Aesthetic Medical International Holdings Group Limited (PAIYY)?
Revenue at Aesthetic Medical International Holdings Group Limited is growing −5.1% versus a year earlier (3y avg +1.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Aesthetic Medical International Holdings Group Limited (PAIYY) generate?
The free cash flow of Aesthetic Medical International Holdings Group Limited is −23.0M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Aesthetic Medical International Holdings Group Limited (PAIYY) carry?
The net debt of Aesthetic Medical International Holdings Group Limited is 215M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Aesthetic Medical International Holdings Group Limited in the live analysis

One click puts Aesthetic Medical International Holdings Group Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.